cinia virus in BSCl cells by interfering with viral maturation. A mutant of the virus (TCTR) which is resistant to this drug was isolated. This mutant also exhibits resistance to another thiosemicarbazone related compound, isatin ,B-thiosemicarbazone (IBT). There is a good correlation between the cross-resistance of the two mutants IBTR and TCTR to TCT and IBT, respectively, and the similar antipoxvirus activity of these two thiosemicarbazone-related compounds.
Isatin f,-thiosemicarbazone (IBT) is an effective antipox drug (15) ; its methyl derivative (Marboran) is clinically used in Africa, India, and in South America. Tsunoda et al. (17) reported that y-thiochromanone-4-thiosemicarbazone (TCT) is also an efficient inhibitor of poxvirus in chicken cells in vitro and in the mouse. Thiosemicarbazone-related compounds, which inhibit the growth of poxviruses, are able to do so either by inhibiting deoxyribonucleic acid (DNA) synthesis or by blocking a maturational event (5) .
In the present study, we determine whether the cross drug resistance of the mutants IBTR (6) and TCTR to TCT and IBT, respectively, indicates a similar mode of inhibition of the wild-type (WT) strain by these two drugs. Titration of virus infectivity. BSC1 cell monolayers in 60-mm plastic petri dishes (Nunc, Denmark) were infected with serial end-point dilutions of virus sample. After 45 min at 37 C, the monolayers were overlayed with Eagle medium containing 1% Special Agar Noble (Difco Laboratories, Detroit, Mich.) and 5% inactivated calf serum. Neutral red (0.0025%) was added 4 days after infection and plaques were counted on the following day.
MATERIALS AND METHODS
Polyacrylamide gel electrophoresis. Gel electrophoresis was performed essentially as described by Summers et al. (16) Fig. 1 ). The inhibition of WT strain by TCT can be reversed after the removal of the drug. When the drug was removed by washing the treated cultures at 7 h after infection, virus growth occurred (Fig. 2) .
Vaccinia DNA is synthesized in HeLa cells mainly between 2 and 5 h after infection and then starts to acquire deoxyribonuclease resistance (4, 12) . Since vaccinia virus multiplies in the cytoplasm of the cell, it is possible to follow viral DNA synthesis, by determination of the incorporated thymidine, into trichloroacetic acid precipitable material after short pulses (4). Infected BSC1 cells were pulse labeled with 4 pCi of radioactive thymidine per ml for 10 min at different times after infection. The cells were washed and the nonionic detergent Nonidet P-40 (0.5%) was added to the cells. Nuclei were removed by centrifugation at 1,000 x g for 2 min (18) . The quantity of radioactively labeled DNA in the cytoplasmic fraction was measured after trichloroacetic acid precipitation. DNA synthesis in the infected cells started between 1 and 2 h after infection, reached the highest level at 3 h, and then declined (Fig. 3) . In TCTtreated cells, the rate of synthesis of the viral DNA was similar to that of untreated, infected cells (Fig. 3) . We then studied the fate of newly synthesized vaccinia viral DNA made in the presence of TCT, using deoxyribonuclease digestion, after sucrose gradient centrifugation. In the presence of TCT, no virus band was detected in WTinfected cells; most of the radioactively labeled DNA was still deoxyribonuclease-susceptible and located at the top of the gradient (Fig. 4) . However, in IBTR-infected cells treated with TCT, [3H ]thymidine appeared in a deoxyribonuclease-resistant band, coincident with infectious virus, in the middle of the sucrose gradient (Fig. 4) .
Synthesis of viral proteins. The failure of vaccinia viral DNA to become resistant to deoxyribonuclease in the presence of TCT might result from the absence of structural proteins. Host protein synthesis is progressively inhibited after vaccinia virus infection, thus permitting the specific labeling of viral polypeptides (3, 10, 11, 13, 14) . The viral proteins are divided into two classes: (i) "early" proteins, which are synthesized at the early period after infection, and which are produced even when from synthesis of host proteins to specific early viral proteins took place also in the presence of TCT and IBT. The effect of TCT and IBT on the formation of late proteins was studied by the addition of [35S] methionine to the cultures between 4 and 7 h after infection and the analysis of the labeled polypeptides in polyacrylamide gels. Similar amounts of labeled methionine were incorporated into the cells. Late viral proteins were produced by WT and IBTR strains of vaccinia virus, also in the presence of IBT and TCT (Fig. 5) .
A major vaccinia virus structural polypeptide was previously shown by pulse chase experiments to form from a higher-molecular-weight precursor; this process appears to be a late step associated with virus maturation (7, 8) . We followed the formation of this structural polypeptide in the presence of TCT and IBT. At 7 h after infection, infected BSC1 cells, treated with TCT and IBT, were labeled with [85S]_ methionine for 30 min. The polypeptides in the cytoplasm of the cells, at the end of the pulse period and after 4 h of chase, were examined by polyacrylamide gel electrophoresis. The precursor polypeptide (P4a) was formed in the presence of TCT and IBT (Fig. 6, pulse) . However, the cleavage, which produces the structural polypeptide 4a, occurred very efficiently in vaccinia-infected BSC1 cultures (control) but was partially inhibited in IBT-treated, infected cultures and even more in TCT-infected cells.
TCT-resistant mutant. A TCT-resistant mutant was isolated in the presence of iodode- oxyuridine and TCT. The neutralization of the mutant by antivaccinia immunoglobulin and its resistance to other thiosemicarbazone-containing compounds were studied:
Induction and isolation of a TCT-resistant mutant (TCTR). A vaccinia mutant (TCT-) which is resistant to TCT was isolated from WT-infected cultures treated with the mutagenic agent iododeoxyuridine in the presence of TCT. Chicken fibroblast monolayers were infected with WT strain of vaccinia virus at an input multiplicity of 1 plaque-forming unit per cell. After 45 min at 37 C, the culture was washed and Eagle medium containing 2% calf serum, iododeoxyuridine (5 ,ug/ml), and TCT (14,uM) was added. The culture was harvested 2 days later, and the virus was used for infection of HeLa and BSC1 cultures in the presence of TCT. Virus from one of these cultures formed plaques in agar-overlaid cultures in the presence of TCT. The TCT-mutant was plaque purified and virus stock was prepared in HeLa cell monolayers in the absence of the drug.
Neutralization of WT, IBTR, and TCTR strains of vaccinia virus by immunoglobulin.
The degree of neutralization of WT, IBTV, and TCTR strains of vaccinia virus by antivaccinia human immunoglobulin was compared. Dilutions of the virus suspensions were incubated at 37 C for 30 min with a constant amount of antivaccinia human immunoglobulin. Although all three virus strains were neutralized by immunoglobulin, there were minor differences in the degree of neutralization ( Table 2) .
Resistance of TCTR virus to several thiosemicarbazone-containing compounds. TCTR virus was examined for its resistance to several thiosemicarbazone-containing compounds. The three drugs tested were IBT, 4-formylacetanilide thiosemicarbazone, and 5-cyanothiophene-2-carboxaldehyde thiosemicarbazone.
Similarly to IBT ¶ TCTR showed resistance toward these three compounds which inhibit the growth of the WT strain ( IBTR was induced and selected in the presence of IBT, whereas the mutant TCTR was isolated independently in the presence of TCT. Each of these mutants was found to be resistant to both IBT and TCT. We wished to find out whether the phenomenon of cross-resistance of the mutants reflects similarity of the mechanisms by which these two drugs inhibit the growth of the WT strain of vaccinia virus.
It was found that the stage in virus growth which is affected by TCT is later than DNA synthesis. Both early and late viral polypeptides are produced but the viral DNA remains susceptible to deoxyribonuclease, unless the drug is removed. Similar findings were obtained with vaccinia-infected cells treated with IBT. In the presence of IBT, partial cleavage of the polypeptide precursor P4a to the core polypeptide 4a is detected; but in infected cells treated with TCT this process is almost completely inhibited. This might result from a more efficient inhibition by TCT in BSC1 cells than by IBT. It is possible to conclude that there is a good correlation between the cross-resistance of the two mutants IBTR and TCTR and the similar antipox activity of IBT and TCT.
